HIV-Associated malignant lymphomas in kenya (Equatorial Africa)

Human Pathology

Volumn 29, Issue 11, 1998, Pages 1285-1289

  Lazzi, Stefano ^b   Ferrari, Filomena ^b   Nyongo, Aggrey ^b   Palummo, Nazzareno ^b   De Milito, Angelo ^b   Zazzi, Maurizio ^b   Leoncini, Lorenzo ^b   Luzi, Pietro ^b   Tosi, Piero ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b NONE

Author keywords

AIDS related lymphoma; Hodgkins's disease; Human herpesvirus 8, Epstein Barr virus; Human immunodeficiency virus

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN SITU HYBRIDIZATION; KENYA; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION;

EID: 0031759294     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(98)90258-1     Document Type: Article

References (41)

1. Biggar RJ, Rabkin CS: The epidemiology of acquired immuno-deficiency syndrome-related lymphomas. Curr Opin Oncol 4:883-893, 1992
2. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36:3S-14S, 1987
3. Rubio R: Hodgkin's disease associated with human immunodeficiency virus infection. Cancer 73:2400-2407, 1994
4. Gerold M, Adler R: Hodgkin's disease as an indicator of AIDS. Medical Hypotheses 45:76-82, 1995
5. Uccini S, Monardo F, Stoppacciaro A, et al: High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients. Int J Cancer 46:581-585, 1990
6. Bellas C, Santòn A, Manzanal A, et al: Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection. Am J Surg Pathol 20:1520-1524, 1996
7. Purtilo DT: Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiancy virus (HIV) as etiological agents of malignant lymphoma and immune deficiency. AIDS Res 2:S1-S6, 1986
8. Gaidano G, Pastore C, Gloghini A, et al: Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS 10:941-949, 1996
9. Levine PH, Blattner WA: The epidemiology of human virus-associated hematologic malignancies. Leukemia 3:54S-59S, 1992
10. Lucas SB, Diomande M, Hounnou A, et al: HIV-associated lymphoma in Africa: An autopsy study in Côte d'Ivoire. Int J Cancer 59:20-24, 1994
11. Lucas SB, Kadio A, Diomande M, et al: Effect of HIV infection on the incidence of lymphoma in Africa. East Afr Med J 73:29-30, 1996
12. Sitas F, Weaving A, Odes R, et al: Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. Br J Cancer 75:1704-1707, 1997
13. Duncan LE, Elliot AM, Tembo G, et al: Limitations of the WHO/CDC clinical case definition for AIDS in Africa. Trop Doct 24:11-12, 1994
14. Gilks CF, Otieno LS, Brindle RJ, et al: The presentation and outcome of HIV-related disease in Nairobi. QJ Med 82:25-32, 1992
15. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361-1392, 1994
16. Volkenandt M, Dicker AP, Fanin R, et al: Polymerase chain reaction analysis of DNA from paraffin-embedded tissue, in White BA (ed): PCR Protocols. Totowa, NJ, Humana, 1993
17. Miller SA, Dykes DD, Polesky HF: A simple salting procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215, 1988
18. Saiki RK, Gelfand DH, Stoffel S, et al: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491, 1988
19. Chang Y, Cesarman E, Pessin MS, et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869, 1994
20. Miura T, Sakuragi J, Kawamura M, et al: Establishment of a phylogenetic survey system for AIDS-related lentiviruses and demonstration of a new HIV-2 subgroup. AIDS 4:1257-1261, 1990
21. Pileri S, Leoncini L, Falini B: Revised European-American lymphoma classification. Curr Opin Oncol 7:401-407, 1995
22. Walter PR, Klotz F, Alfy-Gattas T, et al: Malignant lymphomas in Gabon (Equatorial Africa) : A morphologic study of 72 cases. HUM PATHOL 22:1040-1043, 1991
23. Basset MT, Chokunonga E, Mauchaza B, et al: Cancer in the African population of Harare, Zimbabwe, 1990-1992. Int J Cancer 63:29-36, 1995
24. Cool CD, Bitter MA: The malignant lymphomas of Kenya: Morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases. HUM PATHOL 28:1026-1033, 1997
25. Gatti RA, Godd RA: Occurrence of malignancy in immunodeficiency disease: A literature review. Cancer 28:89-98, 1971
26. Hoover R, Fraumeni JF: Risk of cancer in renal-transplant recipients. Lancet 2:55-57, 1973
27. Ioachim HL, Dorsett B, Cronin W, et al: Acquired immunodeficiency syndrome associated lymphomas: Clinical, pathological, immunological and viral characteristics of 111 cases. HUM PATHOL 22:659-673, 1991
28. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, et al: AIDS-related lymphoma: Histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridisation. Am J Pathol 138:149-163, 1991
29. Carbone A, Gloghini A, Gaidano G, et al: AIDS-related Burkitt's lymphoma: Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 103:561-567, 1995
30. + patients: Clinical and pathological findings in a group often patients. Br J Haematol 95:508-512, 1996
31. Freter CE: Acquired immunodeficiency syndrome-associated lymphomas. J Natl Cancer Inst 10:45, 1990
32. Bacchi CE, Bacchi MM, Rabenhorst SH, et al: AIDS-related lymphoma in Brazil: Histopathology, immunophenotype, and association with Epstein-Barr virus. Am J Clin Pathol 105:230-237, 1996
33. Tirelli U, Errante D, Carbone A, et al: Malignant lymphomas in paticnts with HIV infection. Leukemia and Lymphoma 22:245-257, 1996
34. Spina D, Leoncini L, Megha T, et al: Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas. J Pathol 182:145-150, 1997
35. Wright DH: What is Burkitt's lymphoma? J Pathol 182:125-127, 1997
36. Mbidde EK, Banura C, Desmond-Hellmann SD, et al: African Burkitt's lymphoma and HIV infection. Int Conf AIDS Jun 20-23, 6:3, 102, 1990
37. Ziegler JL: Early studies of Burkitt's tumor in Africa. Am J Pediatr Hematol Oncol 8:63-65, 1986
38. Hamilton-Dutoit SJ, Rea D, Raphael M, et al: Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 143:1072-1085, 1993
39. Rabkin CS, Muller J: Epidemiology and natural history of t(8; 14) recombinations in HIV-infected homosexual men. Natl Conf Hum Retroviruses Relat Infect; Jan 29-Feb 2, 1995, p 90
40. Leoncini L, Spina D, Nyong'o A, et al: Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer 65:781-784, 1996
41. Glaser SL, Lin RJ, Stewart SL, et al: Epstein-Barr virusassociated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 70:375-382, 1997